ArticleOncotarget2016

A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity.

Yao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.